跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Haitam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Haitam
Approved
STANDARD
Haitam
Reyoung Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
70e2ee00334b00a4
Company
Reyoung Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
70e2ee00334b00a4
Drug Approval Philippines Name
Haitam
Product Name
Haitam
Registration Number
DRP-9341-03
Brand Name
Haitam
Generic Name
Ampicillin (as Sodium) + Sulbactam (as Sodium)
Dosage Form
Powder for Injection (I.M./I.V.)
Dosage Strength
500mg/250 mg
Manufacturer
Reyoung Pharmaceutical Co., Ltd.
Importer
Next Chemical Enterprises
Distributor
Dynasty Pharmaceuticals
Issuance Date
28 June 2024
Expiry Date
11 March 2029
Pharmacologic Category
Antibacterial (Penicillin) + Beta-lactamase Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
70e2ee00334b00a4
Type
Standard
Back to Philippines FDA Approvals